These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial. Ionescu DF; Bentley KH; Eikermann M; Taylor N; Akeju O; Swee MB; Pavone KJ; Petrie SR; Dording C; Mischoulon D; Alpert JE; Brown EN; Baer L; Nock MK; Fava M; Cusin C J Affect Disord; 2019 Jan; 243():516-524. PubMed ID: 30286416 [TBL] [Abstract][Full Text] [Related]
10. Rapid inflammation modulation and antidepressant efficacy of a low-dose ketamine infusion in treatment-resistant depression: A randomized, double-blind control study. Chen MH; Li CT; Lin WC; Hong CJ; Tu PC; Bai YM; Cheng CM; Su TP Psychiatry Res; 2018 Nov; 269():207-211. PubMed ID: 30153598 [TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression. Shiroma PR; Thuras P; Wels J; Albott CS; Erbes C; Tye S; Lim KO Transl Psychiatry; 2020 Jun; 10(1):206. PubMed ID: 32591498 [TBL] [Abstract][Full Text] [Related]
12. Low-dose ketamine for treatment resistant depression in an academic clinical practice setting. Feifel D; Malcolm B; Boggie D; Lee K J Affect Disord; 2017 Oct; 221():283-288. PubMed ID: 28666206 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial. Daly EJ; Trivedi MH; Janik A; Li H; Zhang Y; Li X; Lane R; Lim P; Duca AR; Hough D; Thase ME; Zajecka J; Winokur A; Divacka I; Fagiolini A; Cubala WJ; Bitter I; Blier P; Shelton RC; Molero P; Manji H; Drevets WC; Singh JB JAMA Psychiatry; 2019 Sep; 76(9):893-903. PubMed ID: 31166571 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic and Safety Outcomes of Intravenous Ketamine for Treatment-refractory Depression in a Veteran Population: A Case Series. Vitek G; Langenfeld R; Walters RW; Elson A; Driscoll D; Ramaswamy S Mil Med; 2023 Jul; 188(7-8):e2242-e2248. PubMed ID: 36539918 [TBL] [Abstract][Full Text] [Related]
15. Investigation of medical effect of multiple ketamine infusions on patients with major depressive disorder. Zheng W; Zhou YL; Liu WJ; Wang CY; Zhan YN; Li HQ; Chen LJ; Li MD; Ning YP J Psychopharmacol; 2019 Apr; 33(4):494-501. PubMed ID: 30789302 [TBL] [Abstract][Full Text] [Related]
16. Neurocognitive effects of six ketamine infusions and the association with antidepressant response in patients with unipolar and bipolar depression. Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Li M; Ning Y J Psychopharmacol; 2018 Oct; 32(10):1118-1126. PubMed ID: 30260273 [TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression. aan het Rot M; Collins KA; Murrough JW; Perez AM; Reich DL; Charney DS; Mathew SJ Biol Psychiatry; 2010 Jan; 67(2):139-45. PubMed ID: 19897179 [TBL] [Abstract][Full Text] [Related]
18. Cognitive function of patients with treatment-resistant depression after a single low dose of ketamine infusion. Chen MH; Li CT; Lin WC; Hong CJ; Tu PC; Bai YM; Cheng CM; Su TP J Affect Disord; 2018 Dec; 241():1-7. PubMed ID: 30081380 [TBL] [Abstract][Full Text] [Related]
19. Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT. Allen AP; Naughton M; Dowling J; Walsh A; Ismail F; Shorten G; Scott L; McLoughlin DM; Cryan JF; Dinan TG; Clarke G J Affect Disord; 2015 Nov; 186():306-11. PubMed ID: 26275358 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of low-dose ketamine infusion in anxious vs nonanxious depression: revisiting the Adjunctive Ketamine Study of Taiwanese Patients with Treatment-Resistant Depression. Chen MH; Lin WC; Wu HJ; Bai YM; Li CT; Tsai SJ; Hong CJ; Tu PC; Cheng CM; Su TP CNS Spectr; 2021 Aug; 26(4):362-367. PubMed ID: 32419678 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]